Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study
NCT00252005
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
520
Enrollment
INDUSTRY
Sponsor class
Conditions
Deep-Vein Thrombosis
Interventions
DRUG:
Apixaban
Sponsor
Bristol-Myers Squibb